VCAN and cancer: Mechanically, VCAN activates ECs and fibroblasts by activating TLR2, leading to a release of inflammatory cytokines, including tumour necrosis factor-alpha (TNFα), IL-6, and other proinflammatory cytokines, which promote neutrophil infiltration, angiogenesis, and cancer metastasis [264,265,266,267].